journal
Journals Pharmacogenomics and Personali...

Pharmacogenomics and Personalized Medicine

https://read.qxmd.com/read/38046381/implication-of-kdr-polymorphism-rs2071559-on-therapeutic-outcomes-and-safety-of-postoperative-patients-with-gastric-cancer-who-received-s-1-based-adjuvant-chemotherapy-a-real-world-exploratory-study
#21
JOURNAL ARTICLE
Lei Meng, Jun Cao, Li Kang, Gang Xu, Da-Wei Yuan, Kang Li, Kun Zhu
OBJECTIVE: Regimens of S-1-based adjuvant chemotherapy are of great significance in attenuating recurrence risk in postoperative patients with gastric cancer (GC). Kinase insert-domain receptor (KDR) gene plays an essential role in tumor growth and metastasis. This study aimed to investigate the implication of KDR genotyping on the therapeutic outcomes of patients with gastric cancer (GC) who received S-1-based adjuvant chemotherapy. METHODS: A total of 169 postoperative GC with pathological staging of II and III and no metastasis who received S-1-based adjuvant chemotherapy were included retrospectively...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/38023824/identification-of-a-prognostic-gene-signature-based-on-lipid-metabolism-related-genes-in-esophageal-squamous-cell-carcinoma
#22
JOURNAL ARTICLE
Guo-Yi Shen, Peng-Jie Yang, Wen-Shan Zhang, Jun-Biao Chen, Qin-Yong Tian, Yi Zhang, Bater Han
BACKGROUND: Dysregulation of lipid metabolism is common in cancer. However, the molecular mechanism underlying lipid metabolism in esophageal squamous cell carcinoma (ESCC) and its effect on patient prognosis are not well understood. The objective of our study was to construct a lipid metabolism-related prognostic model to improve prognosis prediction in ESCC. METHODS: We downloaded the mRNA expression profiles and corresponding survival data of patients with ESCC from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/38023823/clinical-characteristics-and-prognosis-of-acute-myeloid-leukemia-patients-with-protein-tyrosine-phosphatase-non-receptor-type-11-gene-mutation
#23
JOURNAL ARTICLE
Rui Huang, Yi-Ting Zhang, Yu Lin, Ru-Li Pang, Zhi Yang, Wei-Hua Zhao
OBJECTIVE: The purpose of our study was to investigate the clinical characteristics, molecular biological characteristics and prognosis of acute myeloid leukemia (AML) patients with protein tyrosine phosphatase non-receptor type 11 (PTPN11) gene mutation. METHODS: The clinical data of 30 newly diagnosed adult AML patients with PTPN11 gene mutation were analyzed retrospectively. Kaplan-Meier and Cox proportional risk regression model were examined for prognostic analysis and prognostic factor screening...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37964785/plp2-could-be-a-prognostic-biomarker-and-potential-treatment-target-in-glioblastoma-multiforme
#24
JOURNAL ARTICLE
Hao Qiao, Huanting Li
OBJECTIVE: This study aimed to discern the association between PLP2 expression, its biological significance, and the extent of immune infiltration in human GBM. METHODS: Utilizing the GEPIA2 and TCGA databases, we contrasted the expression levels of PLP2 in GBM against normal tissue. We utilized GEPIA2 and LinkedOmics for survival analysis, recognized genes co-expressed with PLP2 via cBioPortal and GEPIA2, and implemented GO and KEGG analyses. The STRING database facilitated the construction of protein-protein interaction networks...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37941790/personalized-approaches-to-antiplatelet-treatment-for-cardiovascular-diseases-an-umbrella-review
#25
REVIEW
Angelo Oliva, Davide Cao, Alessandro Spirito, Johny Nicolas, Brunna Pileggi, Karim Kamaleldin, Birgit Vogel, Roxana Mehran
Antiplatelet therapy is the cornerstone of antithrombotic prevention in patients with established atherosclerosis, since it has been proven to reduce coronary, cerebrovascular, and peripheral thrombotic events. However, the protective effect of antiplatelet agents is counterbalanced by an increase of bleeding events that impacts on patients' mortality and morbidity. Over the last years, great efforts have been made toward personalized antithrombotic strategies according to the individual bleeding and ischemic risk profile, aiming to maximizing the net clinical benefit...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37933333/hepatic-artery-infusion-chemotherapy-sequential-hepatic-artery-embolization-combined-with-operation-in-the-treatment-of-recurrent-massive-hepatocellular-carcinoma-achieved-pathological-complete-response-a-case-report
#26
Junjie Chen, Xiwen Liao, Yining Wu, Shenjian Ou, Wei Qin, Chengkun Yang, Yufeng Tan, Quan Lao, Minhao Peng, Tao Peng, Xinping Ye
Hepatocellular carcinoma (HCC) recurrence, which encompasses both true recurrence resulting from cancer spread and de novo tumors developing within the same cancer-prone liver, presents a complication in approximately 70% of cases within a 5-year timeframe. The efficacy of neoadjuvant therapy for recurrence after hepatectomy for hepatocellular carcinoma is still unclear. We report a case of recurrent massive advanced hepatocellular carcinoma with pathological complete remission was treated by continuous hepatic arterial infusion chemotherapy (HAIC) and sequential transcatheter arterial embolization (TAE) combined with secondary operation...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37928407/rs217727-of-lncrna-h19-is-associated-with-cervical-cancer-risk-in-the-chinese-han-population
#27
JOURNAL ARTICLE
Jie Dai, Shao Zhang, Yuhan Shi, Jinmei Xu, Weipeng Liu, Jia Yang, Li Shi, Zhiling Yan, Chuanyin Li
BACKGROUND: Long noncoding RNAs (LncRNAs) have been revealed to involve in cervical cancer (CC) developing. The current study was designed to explore the association of SNPs (rs217727, rs2366152, rs1859168, rs10505477) located in the lncRNA H19, HOTAIR, HOTTIP and CASC8 genes with the risk of CC in a Chinese Han population. METHODS: Four SNPs were selected and genotyped in 1426 participants (274 CIN patients, 448 CC patients, and 704 healthy control individuals) using MassArray...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37920752/association-between-ctsk-gene-polymorphisms-and-response-to-alendronate-treatment-in-postmenopausal-chinese-women-with-low-bone-mineral-density
#28
JOURNAL ARTICLE
Hu Yuan, Caihong Wang, Li Liu, Chun Wang, Zhenlin Zhang, Shen Qu
PURPOSE: The aim of this study was to explore the association between CTSK polymorphisms and the response to alendronate treatment in postmenopausal Chinese women with low bone mineral density. PATIENTS AND METHODS: In this study, 460 postmenopausal women from Shanghai were included. All of them were treated with weekly oral alendronate 70 mg, daily calcium 600 mg and vitamin D 125 IU for a year. Four tag single nucleotide polymorphisms (SNPs) in CTSK gene were genotyped...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37904875/a-case-report-of-cardiofaciocutaneous-syndrome-with-map2k1-pathogenic-variant-letter
#29
JOURNAL ARTICLE
Abdul Hadi Furqoni, Indah Fajarwati, Anna Lystia Poetranto
No abstract text is available yet for this article.
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37899885/microarray-expression-profile-and-bioinformatic-analysis-of-circular-rna-in-human-arteriosclerosis-obliterans
#30
JOURNAL ARTICLE
Yu Zhou, Huoying Cai, Lin Huang, Mingshan Wang, Ruiming Liu, Siwen Wang, Yuansen Qin, Chen Yao, Zuojun Hu
BACKGROUND: Arteriosclerosis obliterans (ASO) is the leading cause of nontraumatic lower-extremity amputations. Multiple researches have suggested that circular RNAs (circRNAs) played vital regulatory functions in cancer and cardiovascular disease. Nevertheless, the underlying effect and pathological mechanism of circRNAs in the formation and progression of ASO are still indistinct. METHODS AND RESULTS: This study used microarray analysis to investigate the expression portrait of circRNAs in normal lower extremity arteries and ASO arteries...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37810546/influence-of-cyp450-enzymes-and-abcb1-polymorphisms-on-clopidogrel-response-in-moroccan-patients-with-acute-coronary-syndromes
#31
JOURNAL ARTICLE
Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekkari
INTRODUCTION: Clopidogrel is an antiplatelet prodrug primarily prescribed to prevent or treat acute coronary syndrome (ACS) or acute ischemic stroke (IS), polymorphisms of genes encoding cytochrome P-450 (CYP) and P-glycoprotein transporter, could affect the efficiency of clopidogrel absorption and biotransformation, especially during the first critical hours following its administration. METHODS: The present study was designed to investigate the potential association of clopidogrel responsiveness and 14 polymorphisms in the genes encoding the CYPs (CYP2C9, 2C19, 3A4, 3A5, 1A2, and 2B6), the ATP binding cassette subfamily B member 1 (ABCB1)...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37810545/homocysteine-reduction-for-stroke-prevention-regarding-the-recent-aha-asa-2021-prevention-of-stroke-in-patients-with-stroke-and-transient-ischemic-attack
#32
JOURNAL ARTICLE
Craig Brown, Jianhua Wang, Hong Jiang, Merrill F Elias
Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reduction. Homocysteine reduction was not included in the recommendations. The reduction of homocysteine with low doses of folic acid has been shown to reduce ischemic stroke and all stroke. This has been obscured by studies using high doses of folic acid and cyanocobalamin in patients with renal failure and Methylenetetrahydrofolate reductase (MTHFR) polymorphisms...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37750083/novel-mybpc3-mutations-in-indian-population-with-cardiomyopathies
#33
JOURNAL ARTICLE
Deepa Selvi Rani, Apoorva Kasala, Perundurai S Dhandapany, Uthiralingam Muthusami, Sreejith Kunnoth, Andiappan Rathinavel, Dharma Rakshak Ayapati, Kumarasamy Thangaraj
BACKGROUND: Mutations in Myosin Binding Protein C ( MYBPC3 ) are one of the most frequent causes of cardiomyopathies in the world, but not much data are available in India. METHODS: We carried out targeted direct sequencing of MYBPC3  in 115 hypertrophic (HCM) and 127 dilated (DCM) cardiomyopathies against 197 ethnically matched healthy controls from India. RESULTS: We detected 34 single nucleotide variations in MYBPC3 , of which 19 were novel...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37731406/genome-wide-identification-of-lncrna-and-mrna-for-diagnosing-type-2-diabetes-in-saudi-arabia
#34
JOURNAL ARTICLE
Sarah Albogami
PURPOSE: According to the World Health Organization, Saudi Arabia ranks seventh worldwide in the number of patients with diabetes mellitus. To our knowledge, no research has addressed the potential of noncoding RNA as a diagnostic and/or management biomarker for patients with type 2 diabetes mellitus (T2DM) living in high-altitude areas. This study aimed to identify molecular biomarkers influencing patients with T2DM living in high-altitude areas by analyzing lncRNA and mRNA. PATIENTS AND METHODS: RNA sequencing and bioinformatics analyses were used to identify significantly expressed lncRNAs and mRNAs in T2DM and healthy control groups...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37724295/clinical-significance-of-nat2-genetic-variations-in-type-ii-diabetes-mellitus-and-lipid-regulation
#35
JOURNAL ARTICLE
Yazun Jarrar, Sara Abudahab, Ghasaq Abdul-Wahab, Dana Zaiter, Abdalla Madani, Sara J Abaalkhail, Dina Abulebdah, Hussam Alhawari, Rami Musleh, Su-Jun Lee
BACKGROUND: N-acetyltransferase 2 (NAT2) enzyme is a Phase II drug-metabolizing enzyme that metabolizes different compounds. Genetic variations in NAT2 can influence the enzyme's activity and potentially lead to the development of certain diseases. AIM: This study aimed to investigate the association of NAT2 variants with the risk of Type II diabetes mellitus (T2DM) and the lipid profile among Jordanian patients. METHODS: We sequenced the whole protein-coding region in NAT2 using Sanger's method among a sample of 45 Jordanian T2DM patients and 50 control subjects...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37724294/chromosomal-copy-number-variation-predicts-egfr-tki-response-and-prognosis-for-patients-with-non-small-cell-lung-cancer
#36
JOURNAL ARTICLE
Haiyan He, Hang Ma, Zhuo Chen, Jingliang Chen, Dandan Wu, Xuedong Lv, Jie Zhu
PURPOSE: Chromosomal abnormalities represent genomic signatures linked to cancer prognosis and responses to chemotherapy, immunotherapy, and drug resistance. This study aimed to investigate the impact of chromosome copy number variants (CNVs) on the efficacy of tyrosine kinase inhibitors (TKIs) in EGFR-mutated non-small cell lung cancer (NSCLC) patients, as well as its prognostic implications for progression-free survival (PFS) and overall survival (OS) in EGFR wild-type patients. METHODS: A total of 110 patients with advanced NSCLC were enrolled in this study and categorized into EGFR-mutated and wild-type groups...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37720192/genetic-polymorphism-of-nqo1-influences-susceptibility-to-coronary-heart-disease-in-a-chinese-population-a-cross-sectional-study-and-meta-anaylsis
#37
JOURNAL ARTICLE
Ying-Yan Zhou, Jing-Hua Sun, Li Wang, Yan-Yan Cheng
OBJECTIVE: The present study is to explore the association between NQO1 gene polymorphism and coronary heart disease (CHD) risk. METHODS: This research were selected 80 CHD patients as the observation group and 130 healthy people who participated in normal physical examination during the same period as the control group. NQO1 gene polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. In addition, we conducted a meta-analysis to summarize the results of three relevant previously published adult population studies on the association between NQO1 gene polymorphism and coronary heart disease (CHD) risk...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37705935/a-case-report-of-cardiofaciocutaneous-syndrome-with-map2k1-pathogenic-variant
#38
Qiong Tang, Dai Gong, Xiao-Min Ye, Jun-Ru Xu, Yi-Can Yang, Li-Juan Yan, Li Zou, Xiang-Lan Wen
Craniofacial dysmorphism, cardiac abnormalities, ectodermal abnormalities, psychomotor delay, intellectual disability, and short stature are all hallmarks of the extremely rare disorder known as cardiofaciocutaneous syndrome (CFCS). Although CFCS is considered rare, approximately 300 cases have been documented in the literature. In this report, we discuss a patient diagnosed with CFCS without the typical heart malformations but with craniofacial features, skin abnormalities, intellectual disability, and short stature...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37692338/hsa_circ_0003489-drives-ptx-resistance-of-human-nsclc-cells-through-modulating-mir-98-5p-igf2
#39
JOURNAL ARTICLE
Shaofeng Xia, Chenliang Wang
BACKGROUND: Circular RNAs (circRNAs) demonstrated critical roles within developing tumors and treatment resistance in an increasing body of research. The aim was to look into the functions and processes of hsa_circ_0003489 in the non-small cell lung cancer (NSCLC) paclitaxel (PTX) resistance. METHODS: NSCLC cell-based cultures including A549 and H460 were employed for such an investigation. hsa_circ_0003489, miR-98-5p, and insulin-like growth factor 2 (IGF2) expression-profiles were evaluated with a quantitative real-time polymerase chain reaction (RT-qPCR)...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37650010/pyroptosis-and-inflammasome-related-genes-nlrp3-nlrc4-and-nlrp7-polymorphisms-were-associated-with-risk-of-lung-cancer
#40
JOURNAL ARTICLE
Xin Jing, Yuhui Yun, Xiang Ji, Ende Yang, Pei Li
BACKGROUND: Cancer development and tumor immune microenvironment remodeling are closely linked to pyroptosis and inflammasome activation. However, little information is available in single nucleotide polymorphisms (SNPs) in pyroptosis and inflammasome-related genes in patients with lung cancer. This study aims to evaluate the associations between pyroptosis-related gene ( NLRP3, NLRC4, and NLRP7 ) polymorphisms and the risk of lung cancer. METHODS: The MassARRAY platform was used to genotype six SNPs of the NLRP3, NLRC4, and NLRP7 genes in 660 lung cancer cases and 660 controls...
2023: Pharmacogenomics and Personalized Medicine
journal
journal
42543
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.